Peroxisome proliferator-activated receptor (Ppara) disruption in cardiomyocytes augmented mitochondrial dysfunction, as revealed by damaged mitochondria, lowered ATP contents, decreased mitochondrial complex activities, and increased DRP1/MFN1 protein levels.
[Acta Pharmacologica Sinica]